Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Xysmalobium undulatum
South African perennial plant used in traditional Zulu medicine and commercially formulated as an antidiarrheal remedy in Germany.
Xysmalobium undulatum, a South African perennial plant used in Zulu traditional medicine, is primarily employed as an antidiarrheal and antispasmodic agent. Its key active compounds include uzarin, xysmalorin, pregnane glycosides, and cardenolides, which contribute to its gastrointestinal effects but also pose cardiac risks.
Uzarin and related pregnane glycosides exhibit antispasmodic activity by modulating calcium channels and inhibiting smooth muscle contractions in the gastrointestinal tract. Cardenolides, such as xysmalorin, inhibit Na+/K+-ATPase, which can lead to positive inotropic effects on cardiac muscle but also increase the risk of cardiac toxicity at higher doses. The antidiarrheal effect is likely due to a combination of reduced intestinal motility and enhanced water absorption.
South African perennial plant used in traditional Zulu medicine and commercially formulated as an antidiarrheal remedy in Germany.
Xysmalobium undulatum, a South African perennial plant used in Zulu traditional medicine, is primarily employed as an antidiarrheal and antispasmodic agent. Its key active compounds include uzarin, xysmalorin, pregnane glycosides, and cardenolides, which contribute to its gastrointestinal effects but also pose cardiac risks.
Uzarin and related pregnane glycosides exhibit antispasmodic activity by modulating calcium channels and inhibiting smooth muscle contractions in the gastrointestinal tract. Cardenolides, such as xysmalorin, inhibit Na+/K+-ATPase, which can lead to positive inotropic effects on cardiac muscle but also increase the risk of cardiac toxicity at higher doses. The antidiarrheal effect is likely due to a combination of reduced intestinal motility and enhanced water absorption.